NEW YORK (GenomeWeb) – Genomic Expression and the Kew Group will collaborate to launch Kew's next-generation sequencing-based cancer panel in Scandinavia, the companies said this week.

Kew's CancerPlex assay uses Thermo Fisher's Ion Torrent PGM to analyze over 400 known cancer genes involved in initiation and progression.

The companies will use Kew's panel and Genomic Expression's sample evaluation and informatics technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.